Table 2.

Period of maximum persistent proteinuria and initiation of supportive therapy

MonthsPeriod Maximum Proteinuria (%)ACEi/ARB Start (%)Statin Start (%)
0–66588a61a
7–1214413
13–181647
19–24401
>24b36
Not startedb113
  • ACEi, angiotensin-converting enzyme inhibitor; ARB angiotensin II receptor blocker; statin, 3-hydroxy-3-methyl-glutaryl-CoA-reductase inhibitor.

  • a Start of medication was either before biopsy or during the first 6 months.

  • b Calculation of the maximum persistent proteinuria was restricted to 24 months.